Virtue Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,725
| Closed | -$219K | – | 397 |
|
|
2023
Q3 | $219K | Hold |
1,725
| – | – | 0.04% | 363 |
|
|
2023
Q2 | $219K | Sell |
1,725
-8,328
| -83% | -$1.06M | 0.04% | 360 |
|
|
2023
Q1 | $1.29M | Buy |
+10,053
| New | +$1.29M | 0.21% | 78 |
|
|
2022
Q2 | – | Sell |
-8,709
| Closed | -$1.14M | – | 339 |
|
|
2022
Q1 | $1.14M | Buy |
8,709
+971
| +13% | +$127K | 0.18% | 140 |
|
|
2021
Q4 | $1.18M | Sell |
7,738
-2,983
| -28% | -$455K | 0.17% | 157 |
|
|
2021
Q3 | $1.73M | Buy |
10,721
+332
| +3% | +$53.7K | 0.31% | 71 |
|
|
2021
Q2 | $1.7M | Buy |
10,389
+3,150
| +44% | +$515K | 0.34% | 65 |
|
|
2021
Q1 | $1.09M | Sell |
7,239
-227
| -3% | -$34.2K | 0.26% | 121 |
|
|
2020
Q4 | $1.13M | Buy |
7,466
+2,957
| +66% | +$448K | 0.28% | 112 |
|
|
2020
Q3 | $611K | Buy |
+4,509
| New | +$611K | 0.15% | 185 |
|